FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Esslinger William G. Jr. 		2. Issuer Name and Ticker or Trading Symbol

GREENWAY MEDICAL TECHNOLOGIES INC [ GWAY ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
VP, GC and Secretary
(Last)          (First)          (Middle)

100 GREENWAY BOULEVARD 		3. Date of Earliest Transaction (MM/DD/YYYY)

11/4/2013
(Street)

CARROLLTON, GA 30117
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   11/4/2013     D    35057   D $20.35   0   D  
 
Common Stock   11/4/2013     D    616   D $20.35   0   I   By IRA  
Common Stock   11/4/2013     D    1748   D $20.35   0   I   By Spouse's IRA  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   $5.19   11/4/2013     D         5000      (1) 11/4/2019   Common Stock   5000   $15.16   0   D  
 
Stock Option (right to buy)   $6.92   11/4/2013     D         20000      (2) 6/30/2020   Common Stock   20000   $13.43   0   D  
 
Stock Option (right to buy)   $6.92   11/4/2013     D         2500      (3) 10/18/2020   Common Stock   2500   $13.43   0   D  
 
Stock Option (right to buy)   $7.09   11/4/2013     D         2133      (4) 2/1/2021   Common Stock   2133   $13.26   0   D  
 
Stock Option (right to buy)   $7.09   11/4/2013     D         11067      (5) 2/1/2021   Common Stock   11067   $13.26   0   D  
 
Stock Option (right to buy)   $11.58   11/4/2013     D         7500      (6) 6/28/2021   Common Stock   7500   $8.77   0   D  
 
Stock Option (right to buy)   $13.31   11/4/2013     D         2500      (7) 7/14/2021   Common Stock   2500   $7.04   0   D  
 
Stock Option (right to buy)   $16.25   11/4/2013     D         36000      (8) 5/30/2022   Common Stock   36000   $4.10   0   D  
 
Stock Option (right to buy)   $15.99   11/4/2013     D         32000      (9) 9/24/2022   Common Stock   32000   $4.36   0   D  
 
Stock Option (right to buy)   $5.19   11/4/2013     D         43330      (10) 9/15/2019   Common Stock   43330   $15.16   0   I   By Spouse  

Explanation of Responses:
( 1)  This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $75,800, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 2)  This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $268,600, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 3)  This option, with 25% vesting on August 4, 2011 and the remainder vesting over three years thereafter in monthly installments, was canceled in the merger in exchange for a cash payment of $33,575, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 4)  This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $28,283.58, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 5)  This option, with 25% vesting on February 1, 2012 and the remainder vesting over three years thereafter in monthly installments, was canceled in the merger in exchange for a cash payment of $146,748.42, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 6)  This option, with 25% vesting on June 28, 2012 and the remainder vesting over three years thereafter in monthly installments, was canceled in the merger in exchange for a cash payment of $65,775, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 7)  This option, with 25% vesting on July 14, 2012 and the remainder vesting over three years thereafter in monthly installments, was canceled in the merger in exchange for a cash payment of $17,600, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 8)  This option, with 25% vesting on May 30, 2013 and the remainder vesting over three years thereafter in equal monthly installments, was canceled in the merger in exchange for a cash payment of $147,600, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 9)  This option, with 25% vesting on September 24, 2013 and the remainder vesting over three years thereafter in equal monthly installments, was canceled in the merger in exchange for a cash payment of $139,520, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
( 10)  This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $656,882.8, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Esslinger William G. Jr.
100 GREENWAY BOULEVARD
CARROLLTON, GA 30117

VP, GC and Secretary

Signatures
/s/ William G. Esslinger, Jr. 11/4/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Greenway Medical Technologies Com USD0.0001 (NYSE:GWAY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Greenway Medical Technologies Com USD0.0001 Charts.
Greenway Medical Technologies Com USD0.0001 (NYSE:GWAY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Greenway Medical Technologies Com USD0.0001 Charts.